Clinical Trial Update: Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates how genetic factors influence the metabolism of non-nucleoside reverse transcriptase inhibitors in people with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Vanderbilt University | Conditions: HIV Infections | Phase 1 | Status: COMPLETED